Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Arvinas, Inc. Transaction History
Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group
- $235 Billion
- Q3 2024
A detailed history of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group transactions in Arvinas, Inc. stock. As of the latest transaction made, Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group holds 57,500 shares of ARVN stock, worth $1.45 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
57,500
Previous 57,500
-0.0%
Holding current value
$1.45 Million
Previous $1.53 Billion
7.48%
% of portfolio
0.6%
Previous 0.6%
Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$176 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$169 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$157 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$96.9 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$70 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.34B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...